Contact
Please use this form to send email to PR contact of this press release:
INmune Bio, Inc. Completes Blinded Interim Analysis of Phase II Alzheimer’s Disease Trial
TO:
Please use this form to send email to PR contact of this press release:
INmune Bio, Inc. Completes Blinded Interim Analysis of Phase II Alzheimer’s Disease Trial
TO: